Good to see the recruitment rate is up.
At 22/5/2012 they had 80 patients recruited, or 0.57 per day since t=0.
Between 22/5-25/9, the average recruitment rate was lifted to 1.07 patients per day.
To reach the full cohort of 390 patients by end 2012, the average recruitment rate between now and then will need to rise to 1.80 patients per day.
If they stay at the average rate achieved since May12, recruitment will need to extend to early Mar13.
- Forums
- ASX - By Stock
- TSN
- ha-irinotecan phase iii clinical trial update
ha-irinotecan phase iii clinical trial update , page-5
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online